Mobilization With Movement Versus Joint-Specific Manipulation in De Quervain's Tenosynovitis

April 24, 2025 updated by: Riphah International University

Comparative Study on the Effectiveness of Mobilization With Movement Versus Joint Specific Manipulation on Pain and Function in Patient With Dequervains Tenosynovitis

A comparative study on the effectiveness of mobilization with movement (MWM) versus joint-specific manipulation (JSM) in patients with De Quervain's tenosynovitis typically aims to assess how each technique impacts pain relief and functional improvement. De Quervain's tenosynovitis is an inflammation of the tendons around the thumb and wrist, often causing pain, swelling, and difficulty in performing everyday tasks. The study would likely compare the two interventions by measuring pain levels, range of motion, and overall functional outcomes before and after treatment. MWM involves applying specific, controlled movements while the patient is actively engaging in their joint motion, targeting the tissue's mobility and reducing pain. JSM, on the other hand, focuses on manipulating the joint directly to restore normal function, specifically targeting the wrist and thumb regions affected by the condition.

Study Overview

Detailed Description

A comparative study on the effectiveness of Mobilization with Movement (MWM) versus Joint-Specific Manipulation (JSM) in patients with De Quervain's Tenosynovitis would delve deeper into the physiological mechanisms and clinical outcomes associated with each technique, providing valuable evidence for therapeutic decision-making. De Quervain's Tenosynovitis is a condition characterized by the inflammation of the tendons at the base of the thumb, particularly affecting the abductor pollicis longus and extensor pollicis brevis tendons. This condition is commonly caused by repetitive strain, overuse, or trauma, leading to pain, swelling, and restricted movement, which significantly impacts the patient's daily activities.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • KPK
      • Malakand, KPK, Pakistan, 23060
        • Riphah international University Malakand Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:o Patients clinically diagnosed with De Quervain's tenosynovitis

  • Age between 25-45 years.
  • Positive Finkelstein test.
  • Pain over the first dorsal compartment.
  • Limited wrist and thumb function.
  • Willingness to take part and adhere to the study's guidelines.

Exclusion Criteria:Participants fall in this category would be excluded of the study.

  • Previous surgery of wrist or thumb.
  • Presence of neurological symptoms like numbness, weakeness.
  • Rheumatological conditions like rheumatoid arthritis.
  • Pregnancy.
  • Presence of wrist fracture or osteoporosis.
  • Carpel tunnel syndrome.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Joint-specific Manipulation
Group A

Joint Specific Manipulation

  • High-velocity, low-amplitude thrust to the first carpometacarpal joint
  • Radiocarpal wrist mobilization .Grade III-IV applied at end range. 2. Therapeutic excercises:
  • Ball Toss
  • Static web gripping
  • Gentle ROM activities to maintain mobility
  • Isometric exercises in all direction Ergonomics modifications
Placebo Comparator: Mobilization with Movement
Group B

Mobilization with Movement

  • The proximal row of carpals glides passively radially.
  • Active thumb and wrist movements superimposed on the glide.

Therapeutic excercises:

  • Ball Toss
  • Static web gripping
  • Gentle ROM activities to maintain mobility
  • Isometric exercises in all direction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Reduction - Measured using the Numeric Pain Rating Scale (NPRS) (0-10 scale).
Time Frame: 6 Months
Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS), a validated tool where participants rate their pain on a scale from 0 no pain to 10 worst possible pain.
6 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wrist Function - Assessed with the Patient-Rated Wrist Evaluation (PRWE) (0-100 scale).
Time Frame: 6months
Functional wrist use will be assessed using the Patient-Rated Wrist Evaluation (PRWE), which evaluates pain and disability on a 100-point scale, with higher scores indicating greater impairment. Clinical signs will be assessed using Finkelstein's Test, a standard diagnostic test for De Quervain's tenosynovitis, recorded as positive or negative. Data will be analyzed using pre- and post-intervention comparisons within and between groups to determine the effectiveness of each intervention.
6months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Signs - Evaluated using Finkelstein's Test (Positive/Negative).
Time Frame: 6 months
Clinical Signs will be assessed using Finkelstein's Test, recorded as positive or negative based on the presence of pain during the maneuver.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dr.Nadeem Ahmad, MS, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 17, 2025

Primary Completion (Actual)

February 17, 2025

Study Completion (Actual)

February 17, 2025

Study Registration Dates

First Submitted

February 20, 2025

First Submitted That Met QC Criteria

April 7, 2025

First Posted (Actual)

April 9, 2025

Study Record Updates

Last Update Posted (Actual)

April 25, 2025

Last Update Submitted That Met QC Criteria

April 24, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • REC-01001 Khaista Bacha

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tenosynovitis

Clinical Trials on Joint Specific Manipulation

Subscribe